b_leftb_right
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Editorial

Moving on up: the Journal of Cachexia, Sarcopenia and Muscle

Stephan von Haehling*, Stefan D. Anker

Article first published online: 29 AUG 2015

DOI: 10.1002/jcsm.12064

How to Cite

von Haehling, S., and Anker, S. D. (2015) Moving on up: the Journal of Cachexia, Sarcopenia and Muscle. Journal of Cachexia, Sarcopenia and Muscle, 6: 193196. doi: 10.1002/jcsm.12064.

Author Information

Institute of Innovative Clinical Trial, Department of Cardiology and Pneumology, University of Göttingen Medical School, Göttingen, Germany


As the editors of the Journal of Cachexia, Sarcopenia and Muscle (JCSM), we are proud to announce that the journal has maintained its impact factor, which has now been published by Thomson Scientific as 7.3, placing it number 9 in the ranking of all journals in the field ‘Medicine, General and Internal’ (Table 1) and number 3 among all nutrition journals, among which, however, JCSM is not offficially listed (Table 2). The number of submissions has increased over the last year, but because we decided to stick with four print issues per year, this also means that our rejection rate is now in excess of 80% of submitted articles. Indeed, at the time of this writing, on 9 July 2015, the journal has received 106 submissions in 2015 alone (Figure 1). We are working hard to provide a timely peer review, which is not always easy as it is difficult at times to find appropriate reviewers. In addition, the journal aims to cover not only clinical medicine but also basic research into cachexia, sarcopenia, and muscle pathophysiology in its broadest sense. Authors can help in speeding the review process by suggesting referees who are able to provide a balanced, however, unbiased comment.

Table 1. Top 10 journals in the field ‘Medicine: General & Internal’, adapted from reference 31
 Journal nameImpact factor 2014Items published in 2012 and 2013
1New England Journal of Medicine55.873708
2Lancet45.217589
3Journal of the American Medical Association (JAMA)35.289453
4Annals of Internal Medicine17.810311
5British Medical Journal17.445605
6Archives of Internal Medicine17.333138
7PLoS – Medicine14.429233
8JAMA – Internal Medicine13.116164
9Journal of Cachexia, Sarcopenia and Muscle7.31554
10BMC Med7.249342

Table 2. 
Top 10 journals in the field ‘Nutrition & Dietetics’, where the Journal of Cachexia, Sarcopenia and Muscle is officially not listed, adapted from reference 31
 Journal nameImpact factor 2014Items published in 2012 and 2013
1Progress in Lipid Research10.01565
2Annual Review of Nutrition8.35939
Journal of Cachexia, Sarcopenia and Muscle7.31554
3American Journal of Clinical Nutrition6.770657
4Nutrition Reviews6.076157
5Proceedings of the Nutrition Society5.273121
6Critical Reviews in Food Science and Nutrition5.176148
7International Journal of Obesity5.004450
8Advances in Nutrition4.709175
9Clinical Nutrition4.476294
10International Journal of Behavioral Nutrition and Physical Activity4.111289

Figure 1.

Figure 1.

Number of manuscript submissions to the Journal of Cachexia, Sarcopenia and Muscle by year of publication. *Numbers for 2015 are estimated on the number of submissions until 9 July 2015 (reprinted from von Haehling and Anker[32]).

It does not come as a major surprise that among the best cited articles since the first publication of the JCSM are those that are available for the longest time, that is, those published in 2010 and 2011 (Table 3). Editorials like our ‘facts and numbers’ series that try to summarize knowledge of a specific field in a comprehensive way remain a publication type that we are very much in favour of. This is also highlighted by the popularity of editorials published in 2014 (Tables 4 and 5). We invite scientists to submit such editorials with as many facts and figures as possible on a topic of interest to our readership to submit their work for consideration.

Table 3. Top 10 of the best cited articles since first publication of the Journal of Cachexia, Sarcopenia and Muscle
 First authorTitleTypeYearTimes citedReference
1von HaehlingCachexia as a major underestimated and unmet medical need: facts and numbersEditorial2010151[1]
2LenkSkeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise trainingReview201068[2]
3DaltonThe selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trialOriginal article201167[3]
4von HaehlingAn overview of sarcopenia: facts and numbers on prevalence and clinical impactEditorial201064[4]
5MakWasting in chronic kidney diseaseReview201150[5]
6ElkinaThe role of myostatin in muscle wasting: an overviewReview201145[6]
7FanzaniMolecular and cellular mechanisms of skeletal muscle atrophy: an updateReview201244[7]
8LainscakBody mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary diseaseOriginal article201143[8]
9CesariBiomarkers of sarcopenia in clinical trials—recommendations from the International Working Group on SarcopeniaOriginal article201240[9]
10von HaehlingFrom muscle wasting to sarcopenia and myopenia: update 2012Editorial201239[10]

Table 4. 
Top 10 of the best cited articles published in 2013 in the Journal of Cachexia, Sarcopenia and Muscle
 First authorTitleTypeYearTimes citedReference
1FarkasCachexia as a major public health problem: frequent, costly, and deadlyReview201323[11]
2PatelSerum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literatureReview201322[12]
3MalmstromLow appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle-aged African AmericanOriginal article201318[13]
4VaughanCancer cachexia: impact, mechanisms and emerging treatmentsReview201317[14]
5LenkEffect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure modelOriginal article201316[15]
6GouldCancer cachexia prevention via physical exercise: molecular mechanismsReview201313[16]
7Kalantar-ZadehWhy cachexia kills: examining the causality of poor outcomes in wasting conditionsEditorial201312[17]
8NedergaardSerological muscle loss biomarkers: an overview of current concepts and future possibilitiesReview201311[18]
9Der-TorossianMetabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexiaOriginal article20139[19]
10.SantarpiaButyrylcholinesterase as a prognostic marker: a review of the literatureReview20138[20]
Table 5. Top 10 of the best cited articles published in 2014 in the Journal of Cachexia, Sarcopenia and Muscle
 First authorTitleTypeYearTimes citedReference
1MorleyFrom sarcopenia to frailty: a road less traveledEditorial201415[21]
2AnkerMuscle wasting disease: a proposal for a new disease classificationEditorial20148[22]
3MorleyAre we closer to having drugs to treat muscle wasting disease?Editorial20147[23]
4EbnerHighlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategiesMeeting report20146[24]
HeymsfieldAssessing skeletal muscle mass: historical overview and state of the artReview20146[25]
6ArgilesCachexia: a problem of energetic inefficiencyReview20144[26]
PietraAnamorelin HCI (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profileOriginal article20144[27]
OrmsbeeOsteosarcopenic obesity: the role of bone, muscle, and fat on healthReview20144[28]
9MirzaAttenuation of muscle wasting in murine C2C12 myotubes by epigallocatechin-3-gallateOriginal article20143[29]
KimDaily physical activity and physical function in adult maintenance hemodialysis patientsOriginal article20143[30]

Acknowledgement

The authors of this manuscript certify that they comply with the principles of ethical publishing in the Journal of Cachexia, Sarcopenia and Muscle 2010;1:7–8 (von Haehling S, Morley JE, Coats AJ, and Anker SD).


1
von Haehling S
, Anker SD. Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle 2010; 1: 15.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 152
2
Lenk K
, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle 2010; 1: 921.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 65
3
Dalton JT
, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, Morton RA, Steiner MS. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle 2011; 2: 153161.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 64
4
von Haehling S
, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 2010; 1: 129133.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 65
5
Mak RH
, Ikizler AT, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K. Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle 2011; 2: 925.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 47
6
Elkina Y
, von Haehling S, Anker SD, Springer J. The role of myostatin in muscle wasting: an overview. J Cachexia Sarcopenia Muscle 2011; 2: 143151.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 43
7
Fanzani A
, Conraads VM, Penna F, Martinet W. Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle 2012; 3: 16379.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 42
8
Lainscak M
, von Haehling S, Doehner W, Sarc I, Jeric T, Ziherl K, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle 2011; 2: 8186.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 40
9
Cesari M
, Fielding RA, Pahor M, Goodpaster B, Hellerstein M, van Kan GA, et al. Biomarkers of sarcopenia in clinical trials—recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle 2012; 3: 18190.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 43
10
von Haehling S
, Morley JE, Anker SD. From muscle wasting to sarcopenia and myopenia: update 2012. J Cachexia Sarcopenia Muscle 2012; 3: 213217.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 40
11
Farkas J
, von Haehling S, Kalantar-Zadeh K, Morley JE, Anker SD, Lainscak M. Cachexia as a major public health problem: frequent, costly, and deadly. J Cachexia Sarcopenia Muscle 2013; 4: 1738.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 23
12
Patel SS, Molnar MZ, Tayek JA, Ix JH, Noori N, Benner D, et al. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle 2013; 4: 1929.
Wiley Online Library |
PubMed |
Web of Science® Times Cited: 26
13
Malmstrom TK
, Miller DK, Herning MM, Morley JE. Low appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle-aged African Americans. J Cachexia Sarcopenia Muscle 2013; 4: 17986.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 19
14
Vaughan VC
, Martin P, Lewandowski PA. Cancer cachexia: impact, mechanisms and emerging treatments. J Cachexia Sarcopenia Muscle 2013; 4: 95109.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 17
15Lenk K, Palus S, Schur R, Datta R, Dong J, Culler MD, et al. Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model. J Cachexia Sarcopenia Muscle 2013; 4: 639.
Wiley Online Library |
PubMed |
Web of Science® Times Cited: 16
16
Gould DW
, Lahart I, Carmichael AR, Koutedakis Y, Metsios GS. Cancer cachexia prevention via physical exercise: molecular mechanisms. J Cachexia Sarcopenia Muscle 2013; 4: 11124.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 13
17
Kalantar-Zadeh K
, Rhee C, Sim JJ, Stenvinkel P, Anker SD, Kovesdy CP. Why cachexia kills: examining the causality of poor outcomes in wasting conditions. J Cachexia Sarcopenia Muscle 2013; 4: 8994.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 12
18
Nedergaard A
, Karsdal MA, Sun S, Henriksen K. Serological muscle loss biomarkers: an overview of current concepts and future possibilities. J Cachexia Sarcopenia Muscle 2013; 4: 117.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 11
19
Der-Torossian H
, Wysong A, Shadfar S, Willis MS, McDumm J, Couch ME. Metabolic derangements in the gastrocnemius and the effect of compound A therapy in a murine model of cancer cachexia. J Cachexia Sarcopenia Muscle 2013; 4: 145155.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 10
20
Santarpia L
, Grandone I, Contaldo F, Pasanisi F. Butyrylcholinesterase as a prognostic marker: a review of the literature. J Cachexia Sarcopenia Muscle 2013; 4: 3139.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 10
21
Morley JE, von Haehling S, Anker SD, Vellas B. From sarcopenia to frailty: a road less traveled. J Cachexia Sarcopenia Muscle 2014; 1: 58.
Wiley Online Library |
Web of Science® Times Cited: 17
22
Anker SD
, Coats AJS, Morley JE, Rosano G, Bernabei R, von Haehling S, Kalantar-Zadeh K. Muscle wasting disease: a proposal for a new disease classification. J Cachexia Sarcopenia Muscle 2014; 5: 13.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 8
23
Morley JE
, von Haehling S, Anker SD. Are we closer to having drugs to treat muscle wasting disease? J Cachexia Sarcopenia Muscle 2014; 5: 8387.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 9
24
Ebner N
, Steinbeck L, Doehner W, Anker SD, von Haehling S. Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies. J Cachexia Sarcopenia Muscle 2014; 5: 2734.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 7
25
Heymsfield SB
, Adamek M, Gonzalez MC, Jia G, Thomas DM. Assessing skeletal muscle mass: historical overview and state of the art. J Cachexia Sarcopenia Muscle 2014; 5: 918.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 6
26
Argiles JM
, Fontes-Oliveira CC, Toledo M, Lopez-Soriano FJ, Busquets S. Cachexia: a problem of energetic inefficiency. J Cachexia Sarcopenia Muscle 2014; 5: 279286.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 5
27
Pietra C
, Takeda Y, Tazawa-Ogata N, Minami M, Xia YF, Duus EM, et al. Anamorelin HCI (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia–cachexia syndrome: preclinical profile. J Cachexia Sarcopenia Muscle 2014; 5: 329337.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 4
28
Ormsbee MJ
, Prado CM, Ilich JZ, Purcell S, Siervo M, Folsom A, et al. Osteosarcopenic obesity: the role of bone, muscle, and fat on health. J Cachexia Sarcopenia Muscle 2014; 5: 183192.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 6
29
Mirza KA
, Pereira SL, Edens NK, Tisdale MJ. Attenuation of muscle wasting in murine C2C12 myotubes by epigallocatechin-3-gallate. J Cachexia Sarcopenia Muscle 2014; 5: 339345.

Wiley Online Library |
PubMed |
Web of Science® Times Cited: 3
30
Kim JC
, Shapiro BB, Zhang M, Li Y, Porszasz J, Bross R, et al. Daily physical activity and physical function in adult maintenance hemodialysis patients. J Cachexia Sarcopenia Muscle 2014; 5: 209220.

Wiley Online Library |
PubMed |
CAS |
Web of Science® Times Cited: 3
31
www.webofknowledge.com (accessed 09/07/2015).
32
von Haehling S, Anker SD. More colour to the journal: new style, new publisher, but still cachexia. J Cachexia Sarcopenia Muscle 2015; 6: 1.
Wiley Online Library |
PubMed |
Web of Science®